Evotec

Evotec SE is a global drug discovery and development company based in Hamburg, Germany. Founded in 1993, it specializes in collaborative partnerships with pharmaceutical and biotechnology firms to accelerate the development of new therapeutics. The company focuses on small molecule drugs across various therapeutic areas, including oncology, neurology, and cardiovascular diseases. Evotec offers comprehensive services in drug discovery, including target identification, hit identification, in vitro pharmacology, and integrated chemistry, manufacturing, and controls. The company emphasizes collaborative research and development models, providing shared-risk partnerships and long-term alliances with major pharmaceutical companies. Evotec has established key collaborations with firms like Bayer, Sanofi, and Celgene, and operates facilities in multiple countries, including the UK, Germany, the US, France, Italy, and Austria. The company is committed to advancing precision medicine and gene therapy solutions through innovative, data-driven approaches.